Equinor ASA
XMUN:DNQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Equinor ASA
XMUN:DNQ
|
NO |
|
S
|
Salesforce Inc
DUS:FOO
|
US |
|
H
|
HomeServe PLC
F:XHSB
|
UK |
|
A
|
argenx SE
F:1AE
|
NL |
|
B
|
Bristol-Myers Squibb Co
F:BRM
|
US |
|
L
|
Lloyds Banking Group PLC
F:LLD2
|
UK |
|
A
|
Alnylam Pharmaceuticals Inc
SWB:DUL
|
US |
|
E
|
Eli Lilly and Co
F:LLY
|
US |
Wall St Price Targets
DNQ Price Targets Summary
Equinor ASA
According to Wall Street analysts, the average 1-year price target for DNQ is 32.83 EUR with a low forecast of 23.43 EUR and a high forecast of 39.94 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DNQ's stock price target?
Price Target
32.83
EUR
According to Wall Street analysts, the average 1-year price target for DNQ is 32.83 EUR with a low forecast of 23.43 EUR and a high forecast of 39.94 EUR.
What is the Revenue forecast for Equinor ASA?
Projected CAGR
-1%
Over the last 14 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 3 years is -1%.
What is the Operating Income forecast for Equinor ASA?
Projected CAGR
-2%
Over the last 14 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 5 years is -2%.
What is the Net Income forecast for Equinor ASA?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Net Income has been -7%. The projected CAGR for the next 5 years is 12%.
